| # | Drug | Count |
|---|---|---|
| 0 | GABAPENTIN | 79 |
| 1 | DIAZEPAM | 77 |
| 2 | DIAZEPAM ORAL | 62 |
| 3 | DIAZEPAM ORAL SOLUTION (CONCENTRATE) | 62 |
| 4 | BACLOFEN | 54 |
| 5 | HUMAN IMMUNOGLOBULIN G | 46 |
| 6 | RITUXIMAB | 36 |
| 7 | PREDNISONE | 31 |
| 8 | ESCITALOPRAM | 28 |
| 9 | ESCITALOPRAM OXALATE | 27 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TAFENOQUINE | 1 | 0.0152 |
| 1 | RELACORILANT | 1 | 0.0101 |
| 2 | OLOPATADINE HCL | 1 | 0.0027 |
| 3 | PSYLLIUM HUSK | 3 | 0.0022 |
| 4 | HUMAN IMMUNOGLOBULIN G | 46 | 0.0022 |
| 5 | SULFACETAMIDE SODIUM | 1 | 0.0020 |
| 6 | AMIFAMPRIDINE PHOSPHATE | 4 | 0.0013 |
| 7 | BEROTRALSTAT HYDROCHLORIDE | 1 | 0.0011 |
| 8 | IMMUNE GLOBULIN INTRAVENOUS (HUMAN) | 6 | 0.0009 |
| 9 | TAZAROTENE | 1 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Benzodiazepine [EPC] | 101 |
| 1 | Corticosteroid [EPC] | 58 |
| 2 | Human Immunoglobulin G [EPC] | 56 |
| 3 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 54 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 46 |
| 5 | Insulin Analog [EPC] | 40 |
| 6 | Vitamin C [EPC] | 32 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 29 |
| 8 | Purine Antimetabolite [EPC] | 25 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 23 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunoglobulin G [EPC] | 56 | 0.0027 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 2 | Plasma Kallikrein Inhibitor [EPC] | 2 | 0.0008 |
| 3 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 54 | 0.0006 |
| 4 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 2 | 0.0005 |
| 5 | Provitamin D2 Compound [EPC] | 12 | 0.0004 |
| 6 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 7 | Purine Antimetabolite [EPC] | 25 | 0.0003 |
| 8 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |
| 9 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |